EFFECTIVENESS AND SAFETY OF IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MANTLE CELL LYMPHOMA (MCL) IN BELGIAN ROUTINE CLINICAL PRACTICE WITH A 3‐YEAR FOLLOW‐UP.

Published in:

Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.20_2881

By:

• Janssens, A;
• Snauwaert, S;
• Bron, D;
• Berneman, Z;
• Offner, F;
• Van Bogaert, C;
• De Beleyr, B;
• Smet, A;
• Nielsen, L;
• Wapenaar, R;
• André, M

Publication type:

Article